Related Experiment Video
Updated: Jul 10, 2026
06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Neuromuscular diseases in pregnancy
1Department of Medicine (Division of Neurology), University of British Columbia, Vancouver, Canada. hannah.briemberg@vch.ca
Seminars in Neurology
|October 18, 2007
Summary
Pregnancy can cause focal neuropathies with good recovery, while rare inherited or autoimmune neuromuscular diseases present unique challenges for expectant mothers and their doctors. This review covers recent literature on managing these conditions during pregnancy.
Area of Science:
- Neurology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Pregnancy is associated with focal neuropathies, often resolving post-delivery.
- Preexisting conditions like myasthenia gravis and inherited myopathies/neuropathies are rare but impact pregnancy.
- Understanding these neuromuscular disorders is crucial for maternal and fetal health.
Purpose of the Study:
- To review the most recent literature on neuromuscular diseases during pregnancy and the puerperium.
- To discuss the incidence, etiology, and prognosis of various neuromuscular conditions in pregnant individuals.
- To highlight the challenges and management strategies for neurologists and obstetricians.
Main Methods:
- Literature review of recent scientific publications.
- Synthesis of information on focal neuropathies, inherited neuromuscular diseases, and autoimmune conditions.
- Analysis of clinical impact and management considerations.
Main Results:
- Focal neuropathies increase during pregnancy/puerperium, typically with good prognosis.
- Inherited and autoimmune neuromuscular diseases are rare in childbearing women, with limited data on pregnancy impact.
- Most affected women can deliver healthy infants, but require specialized care.
Conclusions:
- Neuromuscular diseases in pregnancy encompass a range of conditions with varying prognoses.
- Focal neuropathies are often pregnancy-related, while chronic conditions require careful management.
- Collaboration between neurologists and obstetricians is essential for optimal outcomes.
Related Concept Videos
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...